Adverse events · people with burn wounds likely to develop hypertrophic scarring
1 finding from 1 review
no estimate extracted
1 study · 1 participants
GRADE not reported
Major adverse events
Desmopressin showed no clear difference in major adverse events compared with placebo (low certainty).
2 findings from 1 review
Minor adverse events
Desmopressin showed no clear difference in minor adverse events compared with placebo (low certainty).
1 finding from 1 review
Major adverse events
1 finding from 1 review
Minor adverse events
It is very uncertain whether desmopressin changes minor adverse events compared with alpha‐blocker (very low certainty).
1 finding from 1 review
Adverse events · people with leg ulcers undergoing a punch skin‐graft
1 finding from 1 review
Adverse events for mother or child · For interventions, pregnant women, mothers or other caregivers of infants in the first year of life; for outcomes, children up to 6 years…
1 finding from 1 review
Adverse events · women with uterine fibroids
1 finding from 1 review
no estimate extracted
Studies not reported
Low
Adverse events · Children and adolescents having dental treatment under local anaesthetic (restorative and extraction treatments)
1 finding from 1 review
Adverse events · adult participants undergoing cardiac and major abdominal surgery
1 finding from 1 review
Adverse events ‐ temporary or permanent discontinuation/hospitalisation at final · primary membranous nephropathy in adults with nephrotic syndrome
Immunosuppressive treatment probably leads to higher adverse events: temporary/permanent discontinuation or… compared with placebo/no treatment/non‐immunosuppressive supportive treatment (moderate certainty).
1 finding from 1 review
Adverse events · smoking people with infertility
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events · people with burn wounds likely to develop hypertrophic scarring
1 finding from 1 review
Adverse events · people with burn wounds likely to develop hypertrophic scarring
1 finding from 1 review
Adverse events · people aged 60 years and older living in the community
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events · people aged 60 years and older living in the community
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Serious adverse events · people with hepatorenal syndrome
Terlipressin showed no clear difference in serious adverse events compared with placebo or no intervention (low certainty).
1 finding from 1 review
Serious adverse events · people with cirrhosis and hepatorenal syndrome
It is very uncertain whether terlipressin changes serious adverse events compared with other vasoactive drugs (very low certainty).
1 finding from 1 review
RR 0.96 [0.88, 1.06]
474 participants
Very low
Adverse events · women with infertility and at‐risk drinking
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events · malignant cerebral oedema after ischaemic stroke
1 finding from 1 review